Am J Gastroenterol

1. CHEN YT, Chen TI, Yang TH, Yin SC, et al
   Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
   Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002778.
   

   >> Share

   
   
2. CHEN QF, Chen S, Yi JZ, Wang JL, et al
   Recommended Ten Years' Follow-Up Strategy for Small Hepatocellular Carcinoma after Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
   Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002774.
   

   >> Share

   
   
3. LO GH, Yeh JH, Tseng CH, Chen TH, et al
   A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage.
   Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002776.
   

   >> Share

   
   

   
   Am J Pathol

4. NGO HV, Thanh Le TT, Vu HN, Hoang H, et al
   Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage.
   Am J Pathol. 2024 Mar 26:S0002-9440(24)00117.
   

   >> Share

   
   
5. YU YP, Liu S, Geller D, Luo JH, et al
   Serum fusion transcripts to assess the risk of hepatocellular carcinoma and the impact of cancer treatment through machine learning.
   Am J Pathol. 2024 Mar 25:S0002-9440(24)00111.
   

   >> Share

   
   

   
   Anticancer Res

6. OKUNO M, Hatano E, Tada M, Nishimura T, et al
   Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma.
   Anticancer Res. 2024;44:1727-1737.
   

   >> Share

   
   
7. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
   High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
   Anticancer Res. 2024;44:1533-1539.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

8. SEYAMA Y, Sudo K, Yamada T, Tsuchiya K, et al
   Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids.
   Biochem Biophys Res Commun. 2024;709:149816.
   

   >> Share

   
   

   
   BMC Cancer

9. HOU C, Xiong B, Zhou L, Fei Y, et al
   Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma.
   BMC Cancer. 2024;24:387.
   

   >> Share

   
   
10. KANEKO T, Makishima H, Wakatsuki M, Hiroshima Y, et al
    Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study.
    BMC Cancer. 2024;24:383.
    

    >> Share

    
    

    
    BMC Gastroenterol

11. ZHANG ZX, Xv H, Du YN, Lv ZB, et al
    Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI.
    BMC Gastroenterol. 2024;24:117.
    

    >> Share

    
    

    
    Dig Dis

12. LEMMER P, Rohr LC, Henning M, Bulut K, et al
    Liver stiffness determined by transient elastography is a simple and highly accurate predictor for presence of liver cirrhosis in clinical routine.
    Dig Dis. 2024 Mar 25. doi: 10.1159/000538426.
    

    >> Share

    
    

    
    Dig Dis Sci

13. JAFRI F, Saad S, Riaz H, Saleem F, et al
    Lack of Diversity in Transplant Hepatology Fellowship Program Directorship.
    Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08388.
    

    >> Share

    
    
14. SADLIK G, Anderson RC, Lei X, Cen SY, et al
    Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.
    Dig Dis Sci. 2024;69:1004-1014.
    

    >> Share

    
    
15. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
    Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
    Dig Dis Sci. 2024;69:989-1003.
    

    >> Share

    
    
16. JAROENLAPNOPPARAT A, Mettler SK, Guillen H, Chayanupatkul M, et al
    Changes in the Prevalence, Incidence, and Disability-Adjusted Life Years of Non-alcoholic Fatty Liver Disease in the United States Between 1990 and 2019.
    Dig Dis Sci. 2024;69:702-712.
    

    >> Share

    
    
17. KIM RG, Patel S, Satre DD, Shumway M, et al
    Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
    Dig Dis Sci. 2024;69:732-742.
    

    >> Share

    
    
18. YILMAZ L, Bulut A, Aytekin A, Baskonus I, et al
    A Novel Technique for the Management of Persistent Biliary Fistulas Developing After Liver Hydatid Cyst Surgeries: Drain Clamping Technique.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-024-08284.
    

    >> Share

    
    

    
    Endoscopy

19. OGURA T, Iwatsubo T, Okuda A, Ueno S, et al
    Correction: Rescue technique after endoscopic ultrasound-guided hepaticogastrostomy stent dislocation.
    Endoscopy. 2023;55.
    

    >> Share

    
    

    
    Eur Radiol

20. GROSS M, Haider SP, Ze'evi T, Huber S, et al
    Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.
    Eur Radiol. 2024 Mar 27. doi: 10.1007/s00330-024-10624.
    

    >> Share

    
    

    
    Gastroenterology

21. CAMPANI C, Guido M, Marra F
    Elusive hepatic nodules.
    Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
    

    >> Share

    
    

    
    Gut

22. TREBICKA J, Hernaez R, Shawcross DL, Gerbes AL, et al
    Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
    Gut. 2024 Mar 25:gutjnl-2023-330584. doi: 10.1136/gutjnl-2023-330584.
    

    >> Share

    
    

    
    Hepatology

23. 
    Hepatology Highlights.
    Hepatology. 2024;79:255-256.
    

    >> Share

    
    
24. CULLARO G, Allegretti AS, Fenton C, Ge J, et al
    The association between mean arterial pressure and acute kidney injury reversal among decompensated cirrhosis patients.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000858.
    

    >> Share

    
    
25. CHEN Y, Deng X, Li Y, Han Y, et al
    Comprehensive molecular classification predicted microenvironment profiles and therapy response for hepatocellular carcinoma.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000869.
    

    >> Share

    
    
26. ZHAO Q, Chen DP, Chen HD, Wang YZ, et al
    NK-cell-elicited gasdermin-D-dependent hepatocyte pyroptosis induces neutrophil extracellular traps that facilitates HBV-related acute-on-chronic liver failure.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000868.
    

    >> Share

    
    
27. GOLDBERG DT, Yaskolka Meir A, Tsaban G, Rinott E, et al
    Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes; the DIRECT PLUS clinical trial.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000867.
    

    >> Share

    
    
28. FENG X, Feng B, Zhou J, Yang J, et al
    Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells.
    Hepatology. 2024 Mar 28. doi: 10.1097/HEP.0000000000000831.
    

    >> Share

    
    
29. CRUZ C, Prado CM, Gillis C, Martindale R, et al
    Nutritional aspects of prehabilitation in adults with cirrhosis awaiting liver transplant.
    Hepatology. 2024 Mar 28. doi: 10.1097/HEP.0000000000000818.
    

    >> Share

    
    
30. DENG T, Chen G
    Single-cell based molecular classification in systematic treatment of hepatocellular carcinoma: From in silico to bedside.
    Hepatology. 2024 Mar 28. doi: 10.1097/HEP.0000000000000874.
    

    >> Share

    
    

    
    J Clin Oncol

31. CHAVEZ-VILLA M, Ruffolo LI, Line PD, Dueland S, et al
    Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases.
    J Clin Oncol. 2024;42:1098-1101.
    

    >> Share

    
    

    
    J Gastroenterol

32. CORNEJO-PAREJA I, Amiar MR, Ocana-Wilhelmi L, Soler-Humanes R, et al
    Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism.
    J Gastroenterol. 2024;59:329-341.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

33. WANG X, Liu H, Wang Y, Wang P, et al
    Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway.
    J Gastroenterol Hepatol. 2024 Mar 24. doi: 10.1111/jgh.16538.
    

    >> Share

    
    

    
    J Hepatol

34. NADIM MK, Kellum JA, Forni L, Francoz C, et al
    Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting.
    J Hepatol. 2024 Mar 23:S0168-8278(24)00214-9. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
35. PASTA A, Pieri G, Plaz Torres MC, Trevisani F, et al
    Hepatocellular carcinoma in patients with Autoimmune Hepatitis.
    J Hepatol. 2024 Mar 23:S0168-8278(24)00208-3. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
36. STRANDBERG R, Jepsen P, Hagstrom H
    Developing and Validating Clinical Prediction Models in Hepatology-an Overview for Clinicians.
    J Hepatol. 2024 Mar 24:S0168-8278(24)00213-7. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
37. D'AMICO G, Perricone G
    Unaswered questions for non-acute (NAD) and acute (AD) decompensation in cirrhosis.
    J Hepatol. 2024 Mar 26:S0168-8278(24)00210-1. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    Oncogene

38. DENG T, Zhao J, Tong Y, Chen Z, et al
    Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC.
    Oncogene. 2024;43:944-961.
    

    >> Share

    
    

    
    PLoS One

39. OKUBO T, Atsukawa M, Tsubota A, Ono H, et al
    Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease.
    PLoS One. 2024;19:e0299313.
    

    >> Share

    
    
40. KIM A, Kang D, Choi SC, Cho J, et al
    Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score.
    PLoS One. 2024;19:e0301126.
    

    >> Share

    
    
41. CHAISUPASAKUL P, Pekthong D, Wangteeraprasert A, Kaewkong W, et al
    Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
    PLoS One. 2024;19:e0300051.
    

    >> Share

    
    
42. SRIPHOOSANAPHAN S, Pantumongkol W, Kulpeng W, Charonpongsuntorn C, et al
    Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand.
    PLoS One. 2024;19:e0300327.
    

    >> Share

    
    

    
    Transplant Proc

43. ZHAN HS, Wei L, Liu JY, Xiong HF, et al
    Favorable Outcomes of Liver Transplantation for Hepatopulmonary Syndrome.
    Transplant Proc. 2024 Mar 22:S0041-1345(24)00165.
    

    >> Share

    
    

    
    Transplantation

44. EMAMAULLEE J, Bartlett JMA, Bangerth S, Etesami K, et al
    Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure.
    Transplantation. 2024;108:e66-e67.
    

    >> Share

    
    
45. YADAV D, Lal BB, Sood V, Khanna R, et al
    Prognostication in Pediatric Acute Liver Failure Using CHALF Score-"Perspective From the Opposite Shore".
    Transplantation. 2024;108:e64-e65.
    

    >> Share

    
    
46. ASCHER-BARTLETT JM, Bangerth S, Jordan S, Weaver C, et al
    CHALF Score: A Novel Tool to Rapidly Risk Stratify Children in Need of Liver Transplant Evaluation During Acute Liver Failure.
    Transplantation. 2023 Oct 23. doi: 10.1097/TP.0000000000004845.
    

    >> Share

    
    
47. AZOULAY D, Desterke C, Bhangui P, Serrablo A, et al
    Rescue Liver Transplantation for Posthepatectomy Liver Failure: A Systematic Review and Survey of an International Experience.
    Transplantation. 2023 Sep 26. doi: 10.1097/TP.0000000000004813.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share